Abstract
The serum bactericidal activities of ceftriaxone, netilmicin, piperacillin and the combinations of ceftriaxone with each of the two other antibiotics were compared 1, 4 and 24 h after i.v. infusion in six volunteers. One hundred and one clinical isolates were used, including Staphylococcus aureus, Pseudomonas aeruginosa and various Enterobacteriaceae.The highest bactericidal titers were found against the Enterobacteriaceae,geometric means of 1 ∶741 and 1∶851 being obtained for ceftriaxone/netilmicin and ceftriaxone/piperacillin respectively. Against Staphylococcus aureus the geometric mean bactericidal titers of ceftriaxone/piperacillin (1∶105) were markedly higher than ceftriaxone/netilmicin (1∶35). Low bactericidal activity was exhibited by all drugs and combinations tested against Pseudomonas aeruginosa;a geometric mean bactericidal titer of 1∶4.6 was achieved. The serum bactericidal activity of the double beta-lactam combinations was found to be at least equal to that of the combination containing a cephalosporin and an aminoglycoside.
Similar content being viewed by others
References
Klastersky, J., Cappel, R., Daneau, D.: Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrobial Agents and Chemotherapy 1972, 2: 470–475.
Klastersky, J., Daneau, D., Swings, G., Weerts, D.: Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. Journal of Infectious Diseases 1974, 129: 187–193.
Stoeckel, K.: Pharmacokinetics of RocephinR, a highly active new cephalosporin with exceptionally long biological half-life. Chemotherapy 1981, 27, Supplement 1: 42–46.
Neu, H. C., Merepol, J. J., Fu, K. P.: Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase stable cephalosporin. Antimicrobial Agents and Chemotherapy 1981, 19: 414–423.
Angern, P., Probst, P.J., Reiner, R., Then, R.: Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies. Antimicrobial Agents and Chemotherapy 1980, 18: 913–921.
Hinkle, A. M., Bodey, G. P.: In vitro evaluation of Ro 13-9904. Antimicrobial Agents and Chemotherapy 1980, 18: 574–578.
Watanakunakorn, C.: In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin and amikacin againstPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1983, 24: 305–306.
Fass, R. J.: Comparative in vitro activities of beta lactam-tobramycin combinations againstPseudmonas aeruginosa and multi-drug resistant gram-negative enteric bacilli. Antimicrobial Agents and Chemotherapy 1982, 21: 1003–1006.
Machka, K., Dietz, R.: Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin. European Journal of Clinical Microbiology 1983, 2: 246–500.
Kayser, F., Machka, K., Wieczorek, L., Banauch, D., Bablok, W., Braveny, I.: Evaluation of the Micur microdilution systems for antibiotic susceptibility testing of gram-negative and gram-positive bacteria. European Journal of Clinical Microbiology 1982, 1: 361–366.
Machka, K., Baierl, W., Braveny, I.: Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin. European Journal of Clinical Microbiology 1982, 1: 238–242.
Winston, D., Barnes, R., Ho, W., Young, L., Champlin, R., Gale, R.: Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. American Journal of Medicine 1984, 77: 442–450.
Van Laethem, Y., Lagast, H., Klastersky, J.: Serum bactericidal activity of ceftazidime and cefoperazone alone and in combination with amikacin againstPseudomonas aeruginosa andKlebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 1983, 23: 435–439.
Van Laethem, Y., Husson, M., Klastersky, J.: Serum bactericidal activity of azthreonam, cefoperazone and amikacin, alone or in combination, againstEscherichia coli, Klebsiella pneumoniae, Serratia marcescens, andPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1984, 26: 224–227.
Coleman, D. L., Horwitz, R. I., Andriole, V. T.: Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis. American Journal of Medicine 1982, 73: 260–267.
Sculier, J. P., Klastersky, J.: Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia. American Journal of Medicine 1984, 76: 429–435.
Zinner, S. H., Klastersky, J., Gaya, H., Bernard, C., Ryff, J. C., andthe EORTC Antimicrobial Therapy Project Group: In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria andStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1981, 20: 463–469.
Standiford, H. C., Drusano, G. L., Fitzpatrick, B., Tatem, B., Schimpff, S. C.: Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin. Antimicrobial Agents and Chemotherapy 1984, 26: 339–342.
Bodey, G. P.: Synergy. Should it determine antibiotic selection in neutropenic patients? Archives of Internal Medicine 1985, 145: 164–1966.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Machka, K., Röbl, M. & Braveny, I. Comparison of the serum bactericidal activity of ceftriaxone/ piperacillin and ceftriaxone/netilmicin. Eur. J, Clin. Microbiol. 5, 115–118 (1986). https://doi.org/10.1007/BF02013480
Issue Date:
DOI: https://doi.org/10.1007/BF02013480